SPY332.80-2.77 -0.83%
DIA277.19-0.95 -0.34%
IXIC10,782.82-185.53 -1.69%

Amicus Therapeutics Raises the Lower End of its Galafold Revenue Guidance from $160M to $170M

Benzinga · -